L.B. Foster Company (FSTR)
USD 26.68
(-6.55%)
USD 26.68
(-6.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 543.74 Million | 497.49 Million | 513.62 Million | 497.41 Million | 655.05 Million | 626.96 Million |
| Cost of Revenue | 430.93 Million | 407.88 Million | 427.31 Million | 402.4 Million | 533.68 Million | 509.81 Million |
| Gross Profit | 112.81 Million | 89.61 Million | 86.3 Million | 95 Million | 121.37 Million | 117.15 Million |
| Operating Expenses | 102.67 Million | 88.8 Million | 81.83 Million | 79.37 Million | 94.56 Million | 94.77 Million |
| Selling, General and Administrative Expenses | 97.38 Million | 82.65 Million | 75.99 Million | 73.64 Million | 87.98 Million | 87.67 Million |
| Research and Development Expenses | 2.55 Million | 2.21 Million | 2.23 Million | 2.64 Million | 2.61 Million | 2.64 Million |
| Other Expenses | 2.73 Million | 6.14 Million | 5.83 Million | 5.72 Million | 6.57 Million | -42.93 Million |
| Cost and Expenses | 533.6 Million | 496.68 Million | 509.14 Million | 481.77 Million | 628.24 Million | 604.58 Million |
| Operating Income | 10.13 Million | 2.36 Million | 7.54 Million | 17.74 Million | 22.31 Million | -20.55 Million |
| Interest Expense | 5.52 Million | 3.34 Million | 2.95 Million | 3.76 Million | 4.92 Million | 6.15 Million |
| Income Tax Expense | -355 Thousand | 36.68 Million | 1.11 Million | -11.84 Million | -25.17 Million | 4.45 Million |
| Earnings before Tax | 944 Thousand | -8.99 Million | 4.59 Million | 13.98 Million | 17.39 Million | -26.71 Million |
| Net Income | 1.46 Million | -45.67 Million | 3.62 Million | 25.82 Million | 42.56 Million | -31.16 Million |
| Earnings Per Share Basic | 0.14 | -4.26 | 0.34 | 2.45 | 4.09 | -3.01 |
| Earnings Per Share Diluted | 0.13 | -4.26 | 0.34 | 2.42 | 4.09 | -3.01 |
| Weighted Average Shares Outstanding | 10.79 Million | 10.72 Million | 10.62 Million | 10.54 Million | 10.41 Million | 10.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.99 Million | 10.72 Million | 10.75 Million | 10.67 Million | 10.64 Million | 10.36 Million |
| Gross Margin | 0.21 | 0.18 | 0.17 | 0.19 | 0.19 | 0.19 |
| EBIT Margin | 0.05 | 0.02 | 0.03 | 0.05 | 0.04 | -0.02 |
| Profit Margin | 0.00 | -0.09 | 0.01 | 0.05 | 0.06 | -0.05 |
| EBITDA | 25.37 Million | 9.2 Million | 18.35 Million | 29.21 Million | 44.14 Million | -1.93 Million |
| Earnings Before Tax Margin | 0.02 | 0.00 | 0.01 | 0.04 | 0.03 | -0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 140.79 Million | 124.32 Million | 543.74 Million | 134.87 Million | 145.34 Million | 148.03 Million |
| Cost of Revenue | 111.39 Million | 99.28 Million | 430.93 Million | 105.83 Million | 117.12 Million | 115.78 Million |
| Gross Profit | 29.4 Million | 25.03 Million | 112.81 Million | 29.04 Million | 28.22 Million | 32.25 Million |
| Operating Expenses | 24.89 Million | 22.74 Million | 102.67 Million | 28.44 Million | 24.16 Million | 25.9 Million |
| Selling, General and Administrative Expenses | 24.89 Million | 22.74 Million | - | 27.24 Million | 24.16 Million | 24.52 Million |
| Research and Development Expenses | - | - | - | 2.55 Million | - | - |
| Other Expenses | 152 Thousand | 3.53 Million | 888 Thousand | 4.35 Million | -917 Thousand | -719 Thousand |
| Cost and Expenses | 136.29 Million | 122.03 Million | 533.6 Million | 134.27 Million | 141.28 Million | 141.68 Million |
| Operating Income | 4.5 Million | 2.28 Million | 10.13 Million | 601 Thousand | 2.68 Million | 6.34 Million |
| Interest Expense | 1.49 Million | 1.12 Million | 5.52 Million | 1.12 Million | 1.44 Million | 1.57 Million |
| Income Tax Expense | 346 Thousand | 289 Thousand | -355 Thousand | -256 Thousand | -121 Thousand | 563 Thousand |
| Earnings before Tax | 3.16 Million | 4.69 Million | 944 Thousand | -726 Thousand | 326 Thousand | 4.05 Million |
| Net Income | 2.84 Million | 4.43 Million | 1.46 Million | -430 Thousand | 515 Thousand | 3.53 Million |
| Earnings Per Share Basic | 0.26 | 0.41 | - | -0.04 | 0.05 | 0.33 |
| Earnings Per Share Diluted | 0.26 | 0.40 | - | -0.04 | 0.05 | 0.32 |
| Weighted Average Shares Outstanding | 10.79 Million | 10.76 Million | 10.79 Million | 10.78 Million | 10.81 Million | 10.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.06 Million | 10.98 Million | 10.99 Million | 10.78 Million | 10.97 Million | 10.87 Million |
| Gross Margin | 0.21 | 0.20 | 0.21 | 0.22 | 0.19 | 0.22 |
| EBIT Margin | 0.06 | 0.05 | - | 0.03 | 0.02 | 0.05 |
| Profit Margin | 0.02 | 0.04 | 0.00 | -0.00 | 0.00 | 0.02 |
| EBITDA | 7.98 Million | 5.87 Million | - | 4.09 Million | 2.68 Million | 7 Million |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.02 | 0.00 | 0.02 | 0.04 |
TOP-R
BALPHARMA
DII-B
000810
9225
HDYNQ